2269. Clinical Outcomes in Patients with Carbapenem-Non-Susceptible, β-Lactam-Susceptible Pseudomonas aeruginosa Infections

BACKGROUND: Pseudomonas aeruginosa (PsAr) isolates harboring OprD mutations often present phenotypically as carbapenem nonsusceptible but susceptible to antipseudomonal β-lactams (APBLs). It is unknown whether this unique genotype–phenotype combination affects the clinical outcomes of patients infec...

Descripción completa

Detalles Bibliográficos
Autores principales: Gavaghan, Victoria M, Lee, Michelle, Butler, David, Biagi, Mark, Santarossa, Maressa, Harrington, Amanda, Albarillo, Fritzie S, Wenzler, Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810814/
http://dx.doi.org/10.1093/ofid/ofz360.1947

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810814/
http://dx.doi.org/10.1093/ofid/ofz360.1947

Ejemplares similares